“This research was prompted by our own experience undertaking pancreatic screening,” Michael Goggins, MD, professor of pathology, medicine and oncology at Johns Hopkins University School of Medicine and director of the early detection research laboratory at Sol Goldman Pancreatic Cancer Research Center at Johns Hopkins, told Healio. “We found that patients with stage I pancreatic cancer have excellent survival, and so we wanted to examine national trends in stage IA pancreatic cancer diagnoses and outcomes.” Read more . . .
Increases in the proportion of patients diagnosed with pancreatic cancer at an earlier stage and younger age may be due to improvements in early detection and diagnosis, according to study results published in Journal of National Cancer Institute.